Key Highlights
•
A study of over 40,000 people with polymyalgia rheumatica found that prescribing bone-protective drugs (bisphosphonates) alongside steroids was associated with one less bone fracture per year for every 100 people treated. This shows a clear benefit for a common preventive measure in a group at high risk for side effects from long-term steroid use.
Source →
•
Researchers have developed a new assessment tool to help hospitals in low-resource countries like Lebanon prepare for chemical, biological, radiological, or nuclear (CBRN) incidents. This tool, created by experts, covers key areas like decontamination and training, aiming to strengthen healthcare systems against these high-risk events.
Source →
•
A case report details a rare instance where a toxin from unripe ackee fruit, passed through breast milk, caused a life-threatening metabolic crisis in a 5-month-old baby who was a carrier for a genetic metabolic disorder. This highlights a critical, previously under-recognized risk for breastfeeding infants and underscores the need to counsel lactating parents about this specific food hazard.
Source →
•
An analysis of real-world health data mapped to two different common data models (OMOP and ConcePTION) found that the choice of data model can lead to different conclusions about drug safety, such as the protective effect of newer blood thinners against cardiovascular events. This reveals a major challenge in ensuring reliable and reproducible results from real-world evidence studies used for drug monitoring.
Source →
•
A laboratory and data analysis study identified the common flame retardant TBOEP as a potential environmental risk factor for fatty liver disease, showing it promotes fat accumulation in liver cells by disrupting key metabolic pathways. This adds to growing evidence linking everyday chemical exposures to the development of common metabolic diseases.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
